Immunolesioning of nerve growth factor p75 receptor-containing neurons in the rat brain by a novel immunotoxin : anti-p75-anti-mouse IgG-trichosanthin conjugates
In the present study, a comparison of potency between a commercially available immunotoxin, 192-immunoglobulin-SAP (192-IgG), and a novel immunotoxin produced in our laboratory, anti-p75-anti-mouse IgG-trichosanthin conjugates (p75-TCS), was conducted. Both of the immunotoxins were specific for nerve growth factor p75 receptor. Cholinergic neurons in the rat basal forebrain and in the neostriatum were depleted after the injection of either 192-IgG or p75-TCS. These indicate that both types of immunotoxins are potent and useful in performing immunolesioning experiments. In addition, there were variations in potency among the two immunotoxins in different routes of administration. The 192-IgG was more potent than the p75-TCS in the case of ventricular injections. In case of striatal injections, 192-IgG caused serious tissue necrosis and considerable tissue damage in the brain region. In contrast, p75-TCS was potent and caused a selective and specific depletion of cholinergic neurons in the neostriatum. These results indicate that indirect immunotoxins may be more useful for performing immunolesioning experiments in case of brain parenchyma administration.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1999 |
---|---|
Erschienen: |
1999 |
Enthalten in: |
Zur Gesamtaufnahme - volume:846 |
---|---|
Enthalten in: |
Brain research - 846(1999), 2 vom: 06. Nov., Seite 154-63 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kwok, K H [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 10.12.1999 Date Revised 14.06.2019 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM104868988 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM104868988 | ||
003 | DE-627 | ||
005 | 20231222133439.0 | ||
007 | tu | ||
008 | 231222s1999 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0350.xml |
035 | |a (DE-627)NLM104868988 | ||
035 | |a (NLM)10556631 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kwok, K H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Immunolesioning of nerve growth factor p75 receptor-containing neurons in the rat brain by a novel immunotoxin |b anti-p75-anti-mouse IgG-trichosanthin conjugates |
264 | 1 | |c 1999 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 10.12.1999 | ||
500 | |a Date Revised 14.06.2019 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a In the present study, a comparison of potency between a commercially available immunotoxin, 192-immunoglobulin-SAP (192-IgG), and a novel immunotoxin produced in our laboratory, anti-p75-anti-mouse IgG-trichosanthin conjugates (p75-TCS), was conducted. Both of the immunotoxins were specific for nerve growth factor p75 receptor. Cholinergic neurons in the rat basal forebrain and in the neostriatum were depleted after the injection of either 192-IgG or p75-TCS. These indicate that both types of immunotoxins are potent and useful in performing immunolesioning experiments. In addition, there were variations in potency among the two immunotoxins in different routes of administration. The 192-IgG was more potent than the p75-TCS in the case of ventricular injections. In case of striatal injections, 192-IgG caused serious tissue necrosis and considerable tissue damage in the brain region. In contrast, p75-TCS was potent and caused a selective and specific depletion of cholinergic neurons in the neostriatum. These results indicate that indirect immunotoxins may be more useful for performing immunolesioning experiments in case of brain parenchyma administration | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a 192 IgG-saporin |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
650 | 7 | |a Antineoplastic Agents, Phytogenic |2 NLM | |
650 | 7 | |a Cholinergic Agents |2 NLM | |
650 | 7 | |a Immunoglobulin G |2 NLM | |
650 | 7 | |a Immunotoxins |2 NLM | |
650 | 7 | |a Receptor, Nerve Growth Factor |2 NLM | |
650 | 7 | |a Ribosome Inactivating Proteins, Type 1 |2 NLM | |
650 | 7 | |a Trichosanthin |2 NLM | |
650 | 7 | |a 60318-52-7 |2 NLM | |
650 | 7 | |a Choline O-Acetyltransferase |2 NLM | |
650 | 7 | |a EC 2.3.1.6 |2 NLM | |
650 | 7 | |a N-Glycosyl Hydrolases |2 NLM | |
650 | 7 | |a EC 3.2.2.- |2 NLM | |
650 | 7 | |a Saporins |2 NLM | |
650 | 7 | |a EC 3.2.2.22 |2 NLM | |
700 | 1 | |a Law, K B |e verfasserin |4 aut | |
700 | 1 | |a Wong, R N |e verfasserin |4 aut | |
700 | 1 | |a Yung, K K |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Brain research |d 1966 |g 846(1999), 2 vom: 06. Nov., Seite 154-63 |w (DE-627)NLM000001538 |x 1872-6240 |7 nnns |
773 | 1 | 8 | |g volume:846 |g year:1999 |g number:2 |g day:06 |g month:11 |g pages:154-63 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 846 |j 1999 |e 2 |b 06 |c 11 |h 154-63 |